Cavitands as Ligands in Rh-Catalyzed Hydrogenation
and 2D NMR spectra were recorded with a Bruker Avance 400 or
a Bruker Avance 500 spectrometer. All deuterated solvents (Sigma–
Aldrich) were used without any further purification. Chemical
shifts are given in ppm and peaks are referenced relative to the
solvent residual peak (δCHDCl = 5.32 ppm, δCHCl = 7.26 ppm,
δDMSO = 2.49 ppm). All NMR J values are given in Hz. All MS
were recorded with a Bruker MALDI-TOF Autoflex instrument.
Product distributions were analyzed by use of an Agilent gas chro-
matograph 6890N with a FID detector. Melting points were deter-
mined with a Mettler Toledo MP70 Melting Point System.
9.23 (s, 1 H), 9.01 (s, 1 H), 8.91 (s, 1 H), 8.76 (s, 1 H), 8.64 (dd, J
= 4.8, 1.7 Hz, 1 H), 8.49 (s, 1 H), 8.10 (s, 1 H), 7.78 (dt, J = 7.9,
1.9 Hz, 1 H), 7.70 (s, 1 H), 7.60 (s, 1 H), 7.58 (s, 1 H), 7.56 (s, 1
H), 7.53 (s, 1 H), 7.51 (s, 2 H), 7.50 (s, 1 H), 7.36 (s, 2 H), 7.34 (s,
2 H), 7.29 (s, 2 H), 7.27 (s, 2 H), 7.27 (s, 1 H), 7.23 (s, 1 H), 5.74
(t, J = 8.3 Hz, 1 H), 5.67–5.59 (m, 2 H), 5.59–5.52 (m, 1 H), 2.62–
2.18 (m, 18 H), 1.70 (hept, J = 7.9 Hz, 2 H), 1.37–0.89 (m, 27 H),
2
3
0.77 (t, J = 7.6 Hz, 3 H) ppm. FTIR: ν = ν(C–N) 1403; ν(Ar) 1597,
˜
892; ν(C=O) 1664; ν(alkyl) 2967, 2934, 2872; ν(–NH···O=)
3251 cm–1. MS (MALDI, +): calcd for C84H82N8O15 + H+ 1443.6;
found 1443.6.
General Procedure for the Synthesis of Cavitands 2a–d: The nitro
group in 2f was reduced to the corresponding amine 2e followed
by acylation under Schotten–Baumann conditions to afford the de-
sired cavitands 2a–d in good yields after purification by column
chromatography.
Cavitand 2c: M.p. Ͼ250 °C with decomposition. 1H NMR
(500 MHz, [D2]dichloromethane): δ = 9.59 (s, 1 H), 9.45 (s, 1 H),
9.32 (s, 1 H), 8.98 (s, 1 H), 8.77–8.72 (m, 1 H), 8.61–8.55 (m, 2 H),
8.14 (s, 1 H), 7.85–7.81 (m, 1 H), 7.71 (s, 1 H), 7.58 (s, 1 H), 7.56
(s, 1 H), 7.55 (s, 1 H), 7.54 (s, 1 H), 7.52 (s, 1 H), 7.50 (s, 1 H),
7.37 (s, 1 H), 7.35 (s, 2 H), 7.34 (s, 1 H), 7.32 (s, 1 H), 7.30 (s, 1
H), 7.29 (s, 1 H), 7.28 (s, 1 H), 7.27 (s, 1 H), 7.24 (s, 2 H), 7.23 (s,
1 H), 5.73 (t, J = 8.4 Hz, 1 H), 5.63 (dt, J = 12.5, 8.3 Hz, 2 H),
5.57 (t, J = 8.3 Hz, 1 H), 2.59–2.20 (m, 20 H), 1.33–1.17 (m, 18
H), 1.11–1.03 (m, 3 H), 1.04–0.95 (m, 6 H), 0.77 (t, J = 7.6 Hz, 3
A typical synthetic procedure is described. A solution of 2f
(428 mg, 0.313 mmol, 1 equiv.) in THF (25 mL) was placed in a
50 mL two-necked flask. A catalytic amount of Raney-Ni (washed
four times with THF, followed by separation with a magnet and
decantation) was added to this solution. The mixture was stirred
with a magnetic bar and purged with hydrogen (by passing hydro-
gen over the solution for a few seconds). The hydrogenation reac-
tion was performed under hydrogen (1 atm) and at 40 °C for 2 h.
The resulting solution was filtered through a 0.45 μm syringe filter
to remove the catalyst, and the solvent was removed under reduced
pressure, affording 2e (410 mg, 0.306 mmol, 98%).
H) ppm. FTIR: ν = ν(C–N) 1401; ν(Ar) 1599, 892; ν(C=O)
˜
1658; ν(alkyl) 2963, 2935, 2874; ν(–NH···O=) 3253 cm–1. MS
(MALDI, +): calcd for C84H82N8O15 + H+ 1443.6; found 1443.6.
Cavitand 2d: Crystals suitable for X-ray crystal structure analysis
were obtained.[31] M.p. Ͼ250 °C with decomposition. 1H NMR
(400 MHz, [D2]dichloromethane): δ = 9.43 (s, 1 H), 9.38 (s, 1 H),
9.35 (s, 1 H), 9.11 (s, 1 H), 8.36 (s, 1 H), 8.05 (dd, J = 8.3, 1.2 Hz,
1 H), 7.92 (s, 1 H), 7.73 (s, 1 H), 7.63 (s, 1 H), 7.62 (s, 1 H), 7.60
(s, 1 H), 7.57 (s, 1 H), 7.50 (s, 1 H), 7.48 (s, 1 H), 7.47 (s, 2 H),
7.45 (s, 2 H), 7.43 (s, 1 H), 7.37 (s, 1 H), 7.37 (s, 1 H), 7.36 (s, 1
H), 7.35 (s, 2 H), 7.34 (s, 2 H), 7.28 (s, 1 H), 7.27 (s, 1 H), 7.25 (s,
1 H), 5.72 (t, J = 8.3 Hz, 1 H), 5.68–5.59 (m, 2 H), 5.64–5.53 (m,
1 H), 2.55–2.18 (m, 16 H), 1.86–1.57 (m, 4 H), 1.31–1.16 (m, 12
H), 1.04 (ddq, J = 30.3, 15.6, 7.5 Hz, 15 H), 0.76 (t, J = 7.5 Hz, 3
The amino cavitand 2e was immediately used in the next reaction
step – acylation of the amine group under Schotten–Baumann con-
ditions to produce cavitands 2a–d. To obtain 2b, for example, the
experimental procedure consisted of adding a solution of potas-
sium carbonate (1.2 g, 8.68 mmol, 28 equiv.) in water (18 mL) to a
solution of 2e (410 mg, 0.306 mmol, 1 equiv.) in ethyl acetate
(25 mL). Next, solid nicotinoyl chloride (142 mg, 0.96 mmol,
3 equiv.) was added to the above solution in small portions with
vigorous stirring. The mixture was stirred at room temperature for
16 h under nitrogen. After this time, the organic phase was sepa-
rated, dried with anhydrous sodium sulfate, and filtered, and the
solvent was evaporated in vacuo. The solid residue obtained was
purified by flash column chromatography on silica with a gradient
of methanol (0–5%) in dichloromethane to afford 2b (390 mg,
0.27 mmol, 86%) as a solid.
H) ppm. FTIR: ν = ν(C–N) 1402; ν(Ar) 1598, 892; ν(C=O)
˜
1664; ν(alkyl) 2965, 2933, 2872; ν(–NH···O=) 3249 cm–1. MS
(MALDI, +): calcd for C84H82N8O15 + Na+ 1464.6; found 1464.6.
General Procedure for the Synthesis of Reference Ligands 5a–d: Un-
der Schotten–Baumann conditions analogous to those described
for the synthesis of cavitands 2a–d, aniline was acylated to produce
reference ligands 5a–d. Crystallization from water/acetone mixtures
afforded the pure compounds, in 75% yield for 5a, 64% yield for
5b, 43% yield for 5c, and 89% yield for 5d.
By use of similar experimental procedures the cavitand 2a was iso-
lated in 77% yield, 2c in 69% yield and 2d in 79% yield.
Cavitand 2a: Crystals suitable for X-ray crystal structure analysis
were obtained.[31] M.p. Ͼ250 °C with decomposition. 1H NMR
(400 MHz, [D2]dichloromethane): δ = 9.79 (s, 1 H), 9.56 (s, 1 H),
9.54 (s, 1 H), 9.13 (s, 1 H), 8.99 (s, 1 H), 8.72 (s, 1 H), 8.59 (d, J =
4.2 Hz, 1 H), 8.54 (s, 1 H), 8.18 (d, J = 2.6 Hz, 1 H), 8.11 (d, J =
7.8 Hz, 1 H), 7.97 (s, 1 H), 7.89 (td, J = 7.7, 1.7 Hz, 1 H), 7.79 (s,
1 H), 7.77 (s, 1 H), 7.75 (s, 1 H), 7.73 (s, 1 H), 7.50 (ddd, J = 7.6,
4.8, 1.1 Hz, 1 H), 7.42 (s, 1 H), 7.40 (s, 1 H), 7.37 (s, 1 H), 7.36 (s,
1 H), 7.34 (s, 1 H), 7.31 (s, 1 H), 7.27 (s, 1 H), 7.25 (s, 1 H), 7.25
(s, 1 H), 7.24 (s, 1 H), 6.84 (dd, J = 8.7, 2.2 Hz, 1 H), 5.75–5.57
(m, 4 H), 2.52–2.21 (m, 20 H), 1.22 (ddd, J = 16.2, 13.0, 7.6 Hz,
15 H), 1.05 (td, J = 7.1, 4.3 Hz, 9 H), 0.99 (td, J = 7.2, 3.5 Hz, 6
N-Phenylpyridine-2-carboxamide (5a): 1H NMR (500 MHz,
CDCl3): δ = 10.03 (s, 1 H), 8.62 (ddd, J = 4.7, 1.6, 0.9 Hz, 1 H),
8.31 (dt, J = 7.8, 1.0 Hz, 1 H), 7.91 (td, J = 7.7, 1.7 Hz, 1 H), 7.79
(dt, J = 8.7, 1.6 Hz, 2 H), 7.49 (ddd, J = 7.6, 4.8, 1.2 Hz, 1 H),
7.43–7.33 (m, 2 H), 7.19–7.10 (m, 1 H) ppm.[32].
N-Phenylpyridine-3-carboxamide (5b): 1H NMR (500 MHz,
CDCl3): δ = 9.08 (d, J = 1.8 Hz, 1 H), 8.76 (dd, J = 4.8, 1.6 Hz, 1
H), 8.20 (dt, J = 7.9, 2.0 Hz, 1 H), 8.04 (s, 1 H), 7.64 (d, J = 7.8 Hz,
2 H), 7.43 (ddd, J = 7.9, 4.8, 0.8 Hz, 1 H), 7.41–7.35 (m, 2 H),
7.21–7.16 (m, 1 H) ppm.[33]
N-Phenylpyridine-4-carboxamide (5c): 1H NMR (500 MHz, [D6]-
DMSO): δ = 10.48 (s, 1 H), 9.06–8.56 (m, 2 H), 7.97–7.79 (m, 2
H), 7.76 (d, J = 7.7 Hz, 2 H), 7.37 (t, J = 7.9 Hz, 2 H), 7.13 (t, J
= 7.4 Hz, 1 H) ppm.[34]
H) ppm. FTIR: ν = ν(C–N) 1401; ν(Ar) 1599, 892; ν(C=O)
˜
1662; ν(alkyl) 2964, 2935, 2875; ν(–NH···O=) 3261 cm–1. MS
(MALDI, +): calcd for C84H82N8O15 + H+ 1443.6; found 1443.6.
Cavitand 2b: Crystals suitable for X-ray crystal structure analysis
were obtained.[31] M.p. Ͼ250 °C with decomposition. 1H NMR
(400 MHz, [D2]dichloromethane): δ = 9.53 (s, 1 H), 9.41 (s, 1 H),
N-Phenylbenzamide (5d): 1H NMR (500 MHz, CDCl3): δ = 7.88 (s,
1 H), 7.86 (d, J = 1.5 Hz, 2 H), 7.65 (d, J = 7.8 Hz, 2 H), 7.59–
Eur. J. Org. Chem. 2014, 4276–4282
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4281